The National Comprehensive Cancer Network (NCCN) guideline for ICC recommends laboratory tests of serum levels of alpha-fetoprotein (AFP), carbohydrate antigen 19-9 (CA19-9), and carcinoembryonic antigen (CEA). The gene discussed is AFP; the disease is intrahepatic cholangiocarcinoma.